This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,437.66 firm fixed-price delivery order is for the supply of 4,566,778,310 units of the prescription medication Otezla 30 mg tablets. The contract has an ultimate completion date of December 23, 2024 and was awarded on December 20, 2024.
This award is associated with a larger DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999, which serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. In addition to the DLA contract, Amerisourcebergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs.
Generated 3/21/25, 10:03 AM